Screening of pharmaceuticals in surface water bodies of the Pampas region of Argentina
by Yanina Elorriaga; Damián J. Marino; Pedro Carriquiriborde; Alicia E. Ronco
International Journal of Environment and Health (IJENVH), Vol. 6, No. 4, 2013

Abstract: Pharmaceuticals have been included among emerging pollutants due to their continuous input in aquatic environments by wastewater discharges. The aim of the present study was detecting and analysing concentration levels of five commonly used pharmaceuticals in surface water bodies of the Pampas region of Argentina. Analyses were done on the soluble fraction by liquid chromatography with mass spectrometry (HPLC-MS) after solid-phase extraction (SPE) extraction. Results show the presence of pharmaceuticals in 10 out of 11 sampling sites, detecting higher concentrations in sites closer to wastewater discharges. Compounds more commonly found and at higher concentrations were caffeine and ibuprofen, with maximum detected levels of 13.32 and 9.66 µg/L, respectively. Highest detected concentrations of carbamazepine and atenolol were 0.63 and 0.55 µg/L, respectively. The compound less frequently detected and at lower levels of concentration was diclofenac.

Online publication date: Thu, 03-Oct-2013

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Environment and Health (IJENVH):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email